| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |